UBS Group’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.8K | Buy |
|
|||||
|
2025
Q1 | $47.9K | Sell |
|
|||||
|
2024
Q4 | $552K | Buy |
|
|||||
|
2024
Q3 | $283K | Buy |
|
|||||
|
2024
Q2 | $364K | Sell |
|
|||||
|
2024
Q1 | $3.8M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Buy |
|
|||||
|
2023
Q3 | $468K | Sell |
|
|||||
|
2023
Q2 | $564K | Buy |
|
|||||
|
2023
Q1 | $539K | Buy |
|
|||||
|
2022
Q4 | $473K | Buy |
|
|||||
|
2022
Q3 | $236K | Buy |
|
|||||
|
2022
Q2 | $178K | Sell |
|
|||||
|
2022
Q1 | $1.21M | Sell |
|
|||||
|
2021
Q4 | $2.23M | Buy |
|
|||||
|
2021
Q3 | $855K | Buy |
|
|||||
|
2021
Q2 | $746K | Sell |
|
|||||
|
2021
Q1 | $1.85M | Buy |
|
|||||
|
2020
Q4 | $31K | Buy |
|
|||||
|
2020
Q3 | $23K | Sell |
|
|||||
|
2020
Q2 | $116K | Sell |
|
|||||
|
2020
Q1 | $61K | Sell |
|
|||||
|
2019
Q4 | $311K | Sell |
|
|||||
|
2019
Q3 | $1.25M | Buy |
|
|||||
|
2019
Q2 | $9K | Sell |
|
|||||
|
2019
Q1 | $53K | Sell |
|
|||||
|
2018
Q4 | $1.2M | Buy |
|
|||||
|
2018
Q3 | $61K | Buy |
|
|||||
|
2018
Q2 | $10K | Sell |
|
|||||
|
2018
Q1 | $357K | Buy |
|
|||||
|
2017
Q4 | $22K | Buy |
|
|||||
|
2017
Q3 | $12K | Buy |
|
|||||
|
2017
Q2 | $9K | Sell |
|
|||||
|
2017
Q1 | $31K | Sell |
|
|||||
|
2016
Q4 | $266K | Buy |
|
|||||
|
2016
Q3 | $76K | Sell |
|
|||||
|
2016
Q2 | $180K | Buy |
|
|||||
|
2016
Q1 | $65K | Sell |
|
|||||
|
2015
Q4 | $867K | Buy |
|
|||||
|
2015
Q3 | $74K | Buy |
|
|||||
|
2015
Q2 | $125K | Hold |
|
|||||
|
2015
Q1 | $104K | Buy |
|
|||||
|
2014
Q4 | $32K | Buy |
|